Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes
Medical Sciences · 28.06.2026 · 14 (3) · 355
DOI: 10.3390/medsci14030355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 28.06.2026. Verfasst von Francesco Codicè und 7 weiteren Autor:innen. Beteiligte Einrichtung: AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, 10126 Torino, Italy. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Visual Acuity, Mass Screening. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Compagnia di San Paolo, Turin, Fondazione Diabete Torino ONLUS, Italian Ministry for Education, University and Research.
Abstract (Originalsprache)
Background/Objectives: Diabetic retinopathy (DR) is a leading cause of preventable visual impairment, and systematic screening is essential to detect sight-threatening stages before symptoms occur. However, long-term real-world evidence on visual outcomes from structured screening programmes remains limited. This study evaluates, in a retrospective analysis of routinely collected clinical data, the real-life visual outcomes of screening for and treating sight-threatening DR, based on 32 years of data collected in a purpose-built centre implementing the 1990 European Working Party recommendations for screening.
Methods
Screening was performed by retinal photography between 1991 and 2022 in 18,161 patients (63,289 screening episodes). Diabetes specialists graded photographs, referring patients to ophthalmologists when needed. The 10-year trajectories of visual acuity (VA) were assessed in patients with different stages of retinopathy and macular involvement at first screening.
Results
At first screening, two-thirds of patients had no DR, 15% had mild DR, and the remainder had referable DR or a non-assessable fundus. There was no difference by sex. Patients with more severe DR at first screening had lower VA, but this did not worsen over 10 years. Median VA in 514 patients treated with panretinal photocoagulation for pre-proliferative or proliferative DR changed from 0.10 logMAR (7–8/10) to 0.15 (6–8/10), 1874 ± 1252 days after treatment. In 823 patients photocoagulated for diabetic macular edema, median VA remained 0.10 logMAR (7–8/10) before treatment and 1998 ± 1288 days after treatment.
Conclusions
Screening for sight-threatening DR using European Working Party recommendations was feasible in everyday practice and was associated with long-term preservation of visual acuity and a low incidence of severe visual loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AI and Computational Biomedicine Unit, Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
- Diabetic Retinopathy Centre, Department of Medical Sciences, University of Torino, 10126 Torino, Italy.
ORCID-Profile: Tiziana Sanavia, Massimo Porta
Förderung
- Compagnia di San Paolo, Turin
- Fondazione Diabete Torino ONLUS
- Italian Ministry for Education, University and Research
Zitieren
APA
Codicè, F., Sanavia, T., Trento, M., Striglia, E., Baltatescu, A., Fariselli, P., Montanaro, M., & Porta, M. (2026). Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes. Medical Sciences, 14(3), 355. https://doi.org/10.3390/medsci14030355
Vancouver
Codicè F, Sanavia T, Trento M, Striglia E, Baltatescu A, Fariselli P, et al. Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes. Medical Sciences. 2026;14(3):355. doi:10.3390/medsci14030355
BibTeX
@article{Codic2026,
author = {Codicè, Francesco and Sanavia, Tiziana and Trento, Marina and Striglia, Elio and Baltatescu, Anatolie and Fariselli, Piero and Montanaro, Marcello and Porta, Massimo},
title = {Thirty-Two Years Screening for Diabetic Retinopathy in a Single Centre: An Assessment of Visual Outcomes},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {355},
doi = {10.3390/medsci14030355}
}
EUVIMED